The International Conference in Lugano was founded in 1981 to bring together researchers and clinicians dealing with malignant lymphomas. The goal was to integrate knowledge of the disease and to foster multidisciplinary development. Attendance has grown from 300 participants at the first Conference to 4000: the Conference is considered the top world event on lymphoid neoplasms. At the beginning of each Conference, a special workshop features 50-60 of the leading experts who outline the main lines of research regarding this disease.
The International Conference in Lugano was founded in 1981 to bring together researchers and clinicians dealing with malignant lymphomas. The goal was to integrate knowledge of the disease and to foster multidisciplinary development. Attendance has grown from 300 participants at the first Conference to 4000: the Conference is considered the top world event on lymphoid neoplasms. At the beginning of each Conference, a special workshop features 50-60 of the leading experts who outline the main lines of research regarding this disease.
interviste
Evolution, aims and characteristics of Lugano ICML
Evoluzione, obiettivi e caratteristiche dell'ICML di Lugano
Treatment of early stage Hodgkin's Lymphoma
Mantle cell lymphoma: a randomized Phase II trial on young patients
Hodgkin's lymphoma: smart drugs for non-responders
Linfoma di Hodgkin: farmaci intelligenti per i non-responders
Mantle cell lymphoma in the elderly: R-BAC 500 study results
Linfoma mantellare negli anziani: risultati dello studio R-BAC500
